ArticleFrontiers in immunology2026

Commentary: Rituximab combined with lenalidomide for the treatment of marginal zone lymphoma with IgM kappa positivity and cold agglutinin syndrome: a case report.

Zilong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.